FDA's Draft Track and Trace Guidance Is Too Late As Serialization Systems Are Already In Place - Industry
Executive Summary
The pharmaceutical industry sees many problems with US FDA’s draft guidance on product serialization to comply with the Drug Supply Chain Security Act of 2012, including requirements for “absolute uniformity.” Moreover, it’s coming out too late for companies that long ago set up serialization IT systems to comply with a November deadline.